Delivery Order SPE2DB24D2217-SPE2DB25FJVXM

Award Date 12/4/24
Potential Completion Date 12/5/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB25FJVXM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,932.85 firm fixed-price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a specialty medication used in the treatment of diabetes.

The award is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as a primary vehicle for the government to efficiently procure essential medications and medical commodities across multiple therapeutic areas, including specialty drugs, brand-name and generic pharmaceuticals, vaccines, syringes, and other medical supplies.

The contract award does not have a set-aside designation, indicating open competition. By leveraging AmerisourceBergen's extensive distribution capabilities and medical product expertise, the DLA is able to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

Generated 3/5/25, 9:50 AM